Search

everythinglearnresearchcommunity

for

Search:↓

Tofacitinib helped a person with total body hair loss grow hair again without bad side effects.

Chemotherapy can cause skin issues and hair loss, and this guide explains how to manage them.

The document concludes that permanent hair loss conditions are complex, require early specific treatments, and "secondary permanent alopecias" might be a more accurate term than "secondary cicatricial alopecia."

Alopecia areata is a reversible, autoimmune-related hair loss that can have significant emotional impact and uncertain treatment effectiveness.

Some skin conditions are associated with other serious diseases, and office microscopy may miss many fungal infections.

Aging can lead to poorer scalp and hair health, including less hair and more scalp diseases, which should be managed to help older people feel better.

The conclusion is that proper recognition and treatment of skin conditions are crucial for the elderly due to changes in skin, nails, and hair with age, and the impact of these conditions on health and mobility.

Old people's nails often have problems due to body changes, more diseases, and self-care difficulties, affecting their movement and hand use.

Skin fungal infections are more common in older adults due to factors like obesity, poor circulation, reduced mobility, and weakened immune defenses from certain medications.

Aging affects hair density and skin health, and Behcet's disease, a complex condition with no specific test, involves sores and systemic issues, treated with various medications.

Protease Nexin-1 is found in human hair growth cells and is affected by male hormones.

The document concludes that corticosteroids effectively treat vasculitis allergica in over 90% of cases, with long-term kidney issues being the main adverse outcome.

Skin lymphoproliferative disorders are hard to diagnose and often linked to systemic diseases, but most have a good prognosis with accurate diagnosis.

The symposium concluded that hair growth involves complex processes, including the hair follicle life cycle, the role of the dermal papilla, hair strength, pigmentation, and the impact of diseases and treatments like minoxidil on hair and skin.

Cyclosporin doesn't stop hair loss.

VEGF helps hair grow and determines follicle size by increasing blood vessel growth.

Lichen Planus is a less common condition affecting skin and mucous membranes, with various types and associated risk factors, challenging to diagnose, significantly impacts life quality, and may have a risk of cancerous changes in oral lesions.

Hair loss and aging are caused by the breakdown of a key protein in hair stem cells.

The report recommends personalized treatment for women's sexual dysfunctions and more research on effective therapies.

The conclusion is that accurate diagnosis of different types of hair loss requires good teamwork between skin doctors and lab experts.

Lichen planus is a skin condition that can resolve on its own, is linked to hepatitis C, and increases the risk of skin cancer.

Methotrexate treats various disorders by inhibiting DNA synthesis, but careful monitoring is needed to avoid toxicity and manage side effects.

Most people with systemic lupus erythematosus have skin problems, and skin symptoms are often the first sign of the disease.

Targeting the IL-23/IL-17 pathway effectively treats several inflammatory skin diseases.

Eczema and fungal infections are the most common skin problems in Japan, with different age groups and genders affected by various conditions.

Vitamin D is important for skin health and may affect conditions like psoriasis and hair loss, but more research is needed to understand its role fully.

The skin's internal clock affects healing, cancer risk, aging, immunity, and hair growth, and disruptions can harm skin health.

Low doses of some substances can be beneficial, while high doses can be harmful or toxic.

Smoking harms the skin, causing early aging and increasing cancer risk, but stopping smoking can improve skin health.

The paper concludes that the 1982 criteria for diagnosing systemic lupus erythematosus need updating to improve accuracy and involve dermatologists in the process.